Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-983-9 | CAS number: 9075-68-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 25 - July 9, 1982
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- (1981)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Pullulanase
- EC Number:
- 232-983-9
- EC Name:
- Pullulanase
- Cas Number:
- 9075-68-7
- Molecular formula:
- not available
- IUPAC Name:
- Pullulanase
- Reference substance name:
- Protein as a constituent of enzyme deriving from the fermentation or extraction process
- Molecular formula:
- Not available
- IUPAC Name:
- Protein as a constituent of enzyme deriving from the fermentation or extraction process
- Reference substance name:
- Inorganic salts as a constituent of enzyme deriving from the fermentation or extraction process
- Molecular formula:
- Not available.
- IUPAC Name:
- Inorganic salts as a constituent of enzyme deriving from the fermentation or extraction process
- Reference substance name:
- Carbohydrates constituent of enzyme deriving from the fermentation or extraction process
- Molecular formula:
- Not available.
- IUPAC Name:
- Carbohydrates constituent of enzyme deriving from the fermentation or extraction process
- Reference substance name:
- Lipids as a constituent of enzyme deriving from the fermentation or extraction process
- Molecular formula:
- Not available.
- IUPAC Name:
- Lipids as a constituent of enzyme deriving from the fermentation or extraction process
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): Pullulanase SP 247, Toxbatch PPY 1323
- Substance type: UVCB
- Physical state: Powder
- Lot/batch No.: PPY 1323
- Expiration date of the lot/batch: At least stable until 1992-08-05
- Stability under test conditions: The test material is stable for at least 24 hours at room temperature
- Storage condition of test material: 4 degrees of Celcius
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Constituent 5
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: Charles River UK Ltd, Kent UK.
- Housing: Five animals per cage, the sexes being kept separately
- Weight at time of dosing: Between 155-167 g (females), 195-202 g (males)
- Housing: In animal room with control of temperature and humidity
- Diet: Standard diet ad libitum
- Water: Tap water ad libitum
- Temperature (°C): 18-24°C
- Humidity: 45-70 %
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: An exposure chamber connected to 2 Wright dust feeders (Wright, B. M., 1950, J. Sci. Instr., 27, 12.) and two Broomwade compressors (type CAR 31) to supply compressed air.
- Exposure chamber volume: 41.5 L
- Method of holding animals in test chamber: Nose only
- Source and rate of air: Air was supplied in a volume of 18.0 L/min to prepare and disperse the dust.
- Method of conditioning air: The dust feeders were positioned at the base of the chamber. An extract duct at the top of the chamber was connected by way of a high efficiency filter to a metered vacuum system. The test compound particles were dispersed evenly throughout the chamber and exited through a series of small holes connected to a filtered vacuum line operating at a flow rate of approximately 2.0 L/min greater that the input flow rate (to reduce risk of contamination of the environment). The exposure chamber provided a single pass of the freshly generated dust.
- System of generating particulates/aerosols: The test atmosphere was produced by 2 Wright dust feeders. A scraper blade remoced powder from a prepacked canister at a steady rate. The loose powder was removed from the canister by a stream of clean, dry, compressed air. The dust passed through a jet and was impinged on a baffled plate to break up any aggregates. The air containing the finely dispersed dust was passed directly into the exposure chamber.
- Method of particle size determination: The particle size was estimated twice during the exposure period by using an Andersen Mini Sampler (2000 Inc., Salt Lake City, Utah, USA). The device consists of 4 metal impaction plates and a back-up glass fiber filter housed within an anodized aluminium can. The sampler was positioned and temporarily sealed in a port in the exposure chamber in the animal’s breathing zone. Chamber air was drawn through the sampler at a rate of 1.4 L/min using an Andersen 2000 vacuum pump for a recorded time period. Each impaction plate together with the back-up filter was weighed before and after sampling and the weight of material collected on each stage calculated by difference. From the results obtained the weight distribution of 5 size ranges of particles was calculated.
- Treatment of exhaust air: An extract duct at the top of the chamber was connected by way of a high efficiency filter to a metered vacuum system. The particles dispersed evenly throughout the chamber, and were exited through a series of small holes connected to a filtered vacuum line operation at a flow rate of approximately 2. 0 L/min greater than the input flow rate and therefore reducing risk of contamination of the environment.
- Temperature, pressure in air chamber: 21oC ± 2oC, normal pressure of the atmosphere
TEST ATMOSPHERE
- Brief description of analytical method used: The chamber concentration was estimated gravimetrically during the exposure periods at regular intervals. The gravimetric method used employed pressed glass fiber filters placed in a filter holder. The conical input side of the holder was positioned and temporarily sealed in a port in the exposure chamber in the animal’s breathing zone. Chamber air was drawn through the filter at a measured rate of 2.5 L/min using a vacuum pump. Seven air samples (volume between 15-37.5 L) during the 4 hour exposure period were taken. The collected material was weighed to determine the concentration of test material in the exposure chamber.
- Samples taken from breathing zone: yes
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: 25.71% respirable (< 4.7 um)
- MMAD (Mass mean aerodynamic diameter) / GSD (Geometric st. dev.): MMAD=15.0 µm, GSD=4.1 µm - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- >= 4 h
- Concentrations:
- 2.14 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations for clinical signs of effect: During exposure, immediately after and frequently for the first 4 hours post exposure, and at least twice daily during the subsequent 14 day post exposure period. Weighing: Immediately before dosing and on days 2, 3, 4, 7, 10 and 14 post exposure.
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 2.14 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortality.
- Clinical signs:
- other: All animals showed initial struggling with increased urination and defecation during the early part of the exposure period. Test animals showed a slight reduction in respiratory rate during exposure. In addition a clear nasal secretion and red nasal encru
- Body weight:
- No effects on body weight gain were observed.
- Gross pathology:
- No abnormalities.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Pullulanase causes only minimal evidence of toxicity in rats after 4 hours of inhalation of a concentration of 2.14 mg/L. Thus it was concluded that the LC50 for pullulanase is in excess of 2.14 mg/L.
- Executive summary:
In accordance with OECD guideline No. 403, a Limit Test was performed with two groups, one control group and one test group. Both groups consisted of 5 females and 5 males rats.
The animals were exposed by snout only exposure for 4 hours to air containing dust of Pullulanase, batch PPY1323, at a concentration of 2.14 mg/L.
Particle size measurements revealed that the respirable fraction (% of aerosol mass < 4.7 um) was 25.71%. The animals were observed during exposure, immediately after and frequently for the first 4 hours post exposure, and at least twice daily during the subsequent 14 day post exposure period. They were weighed immediately before dosing and on days 2, 3, 4, 7, 10 and 14 post-exposure. After the observation period, the animals were sacrificed and examined pathologically.
The clinical signs observed during exposure of the test material were confined to a slightly depressed respiratory rate, a clear nasal secretion after 30 minutes exposure and red nasal encrustation after 3 hours. No animals died during exposure or during the observation period, and the pathological examination revealed no abnormalities.
In conclusion, the LC50 (4 h) for pullulanase in Sprague-Dawley rats was not demonstrated other than an indicuation of the value being in excess of 2.14 mg/L.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.